Brintellix (vortioxetine) to be renamed Trintellix- Takeda Pharma + Lundbeck
Brintellix (vortioxetine) an anti depressant from Lundbeck and Takeda Pharma has been re-named Trintellix in the US. The FDA had noted prescribing errors that had occurred due to confusion of Brintellix with blood thinner Brilinta (ticagrelor) from AstraZeneca. The change will take place in June 2016.
In the EU, ticagrelor has the brand name Brilique.
Related news and insights
Medtronic announced the United States launch of the Penditure left atrial appendage (LAA) exclusion system, an implantable clip preloaded on a single-use delivery system for LAA management during concomitant cardiac surgery procedures
GSK plc announced positive headline results from a planned interim efficacy analysis of the DREAMM-7 head-to-head phase III trial evaluating belantamab mafodotin as a second-line treatment for relapsed or refractory multiple myeloma